These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 8864436

  • 1. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H, LeGuern C, Sachs DH, Sykes M.
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH.
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [Abstract] [Full Text] [Related]

  • 4. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M.
    Clin Transplant; 1996 Aug 01; 10(4):357-63. PubMed ID: 8884109
    [Abstract] [Full Text] [Related]

  • 6. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M.
    Eur J Immunol; 2005 Sep 01; 35(9):2679-90. PubMed ID: 16082727
    [Abstract] [Full Text] [Related]

  • 7. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H, Takeuchi Y, Shaffer J, Sykes M.
    Transplantation; 2006 Jul 27; 82(2):251-7. PubMed ID: 16858289
    [Abstract] [Full Text] [Related]

  • 8. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST.
    J Immunol; 1996 Oct 01; 157(7):2820-9. PubMed ID: 8816385
    [Abstract] [Full Text] [Related]

  • 9. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.
    Nikolic B, Khan A, Sykes M.
    Biol Blood Marrow Transplant; 2001 Oct 01; 7(3):144-53. PubMed ID: 11302548
    [Abstract] [Full Text] [Related]

  • 10. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A, Narumi S, Hashimoto N, Itabashi Y, Hakamada K, Sasaki M.
    Transplant Proc; 2004 Oct 01; 36(8):2418-22. PubMed ID: 15561266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 01; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 13. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Sachs DH, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363
    [Abstract] [Full Text] [Related]

  • 14. Long-term engraftment of precultured post-5-fluorouracil allogeneic marrow in mice conditioned with a nonmyeloablative regimen: relevance for a gene therapy approach to tolerance induction.
    Hayashi H, LeGuern C, Sachs DH, Sykes M.
    Transpl Immunol; 1996 Mar 15; 4(1):86-90. PubMed ID: 8762020
    [Abstract] [Full Text] [Related]

  • 15. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.
    J Surg Res; 2006 Jan 15; 130(1):102-9. PubMed ID: 16183077
    [Abstract] [Full Text] [Related]

  • 16. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
    Sharabi Y, Abraham VS, Sykes M, Sachs DH.
    Bone Marrow Transplant; 1992 Mar 15; 9(3):191-7. PubMed ID: 1387333
    [Abstract] [Full Text] [Related]

  • 17. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H, Kurtz J, Shaffer J, Sykes M.
    J Immunol; 2001 Mar 01; 166(5):2970-81. PubMed ID: 11207246
    [Abstract] [Full Text] [Related]

  • 18. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Mar 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999 Mar 01; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.